These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 28397672

  • 1. [Successful treatment of severe dabigatran intoxication with idarucizumab in a patient with acute kidney injury].
    Poulsen CG, Bestle M, Boesby L.
    Ugeskr Laeger; 2017 Feb 13; 179(7):. PubMed ID: 28397672
    [Abstract] [Full Text] [Related]

  • 2. Idarucizumab for dabigatran overdose.
    Peetermans M, Pollack C, Reilly P, Liesenborghs L, Jacquemin M, Levy JH, Weitz JI, Verhamme P.
    Clin Toxicol (Phila); 2016 Sep 13; 54(8):644-6. PubMed ID: 27224445
    [Abstract] [Full Text] [Related]

  • 3. idarucizumab (PRAXBIND°). Don't rely too heavily on this dabigatran antidote.
    Prescrire Int; 2016 Nov 13; 25(176):260-263. PubMed ID: 30715821
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience.
    Sheikh-Taha M.
    Am J Cardiovasc Drugs; 2019 Feb 13; 19(1):59-64. PubMed ID: 30203330
    [Abstract] [Full Text] [Related]

  • 7. Idarucizumab, a Specific Reversal Agent for Dabigatran: Mode of Action, Pharmacokinetics and Pharmacodynamics, and Safety and Efficacy in Phase 1 Subjects.
    Reilly PA, van Ryn J, Grottke O, Glund S, Stangier J.
    Am J Med; 2016 Nov 13; 129(11S):S64-S72. PubMed ID: 27569674
    [Abstract] [Full Text] [Related]

  • 8. Idarucizumab administration for reversing dabigatran effect in an acute kidney injured patient with bleeding.
    Quintard H, Viard D, Drici MD, Ruetsch C, Samama CM, Ichai C.
    Thromb Haemost; 2017 Jan 05; 117(1):196-197. PubMed ID: 27734073
    [No Abstract] [Full Text] [Related]

  • 9. Management of dabigatran after overdosage: two case reports and suggestions for monitoring.
    Billoir P, Girault C, Barbay V, Boyer D, Grangé S, Fresel M, Chrétien MH, Le Cam Duchez V.
    Blood Coagul Fibrinolysis; 2018 Nov 05; 29(7):653-655. PubMed ID: 30045050
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Spotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatran.
    Sié P.
    Drug Des Devel Ther; 2016 Nov 05; 10():1683-9. PubMed ID: 27274201
    [Abstract] [Full Text] [Related]

  • 12. [Severe dabigatran intoxication complicated by insufficient reversal by idarucizumab].
    Hellfritzsch M, Hvas AM.
    Ugeskr Laeger; 2020 Apr 06; 182(15):. PubMed ID: 32286218
    [Abstract] [Full Text] [Related]

  • 13. Idarucizumab: First Global Approval.
    Burness CB.
    Drugs; 2015 Dec 06; 75(18):2155-61. PubMed ID: 26578027
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reversal of dabigatran-associated bleeding using idarucizumab: review of the current evidence.
    Giustozzi M, Verso M, Agnelli G, Becattini C.
    J Thromb Thrombolysis; 2017 Nov 06; 44(4):527-535. PubMed ID: 28913672
    [Abstract] [Full Text] [Related]

  • 16. Dabigatran Reversal With Idarucizumab in Patients With Renal Impairment.
    Eikelboom JW, van Ryn J, Reilly P, Hylek EM, Elsaesser A, Glund S, Pollack CV, Weitz JI.
    J Am Coll Cardiol; 2019 Oct 08; 74(14):1760-1768. PubMed ID: 31582135
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Management of Dabigatran-Associated Bleeding with Two Doses of Idarucizumab Plus Hemodialysis.
    Marino KK, Santiago RA, Dew RB, Berliner N, Connors JM, Connell NT, Tucker JK.
    Pharmacotherapy; 2016 Oct 08; 36(10):e160-e165. PubMed ID: 27581709
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evidence Supporting Idarucizumab for the Reversal of Dabigatran.
    Pollack CV.
    Am J Med; 2016 Nov 08; 129(11S):S73-S79. PubMed ID: 27568285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.